Variants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the disease
about
Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approachA genetic score for the prediction of beta-thalassemia severity.α-Globin as a molecular target in the treatment of β-thalassemiaGenetic modifiers of sickle cell diseaseRole of XmnIgG Polymorphism in Hydroxyurea Treatment and Fetal Hemoglobin Level at Isfahanian Intermediate β-Thalassemia Patients.Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.The prevention of thalassemia.Estimation of the difference in HbF expression due to loss of the 5' δ-globin BCL11A binding region.Non-transfusion-dependent thalassemias.Diagnosis and prevention of thalassemia.Advances in technologies for screening and diagnosis of hemoglobinopathies.Preconception carrier screening and prenatal diagnosis in thalassemia and hemoglobinopathies: challenges and future perspectives.Recent patents and technology transfer for molecular diagnosis of β-thalassemia and other hemoglobinopathies.Understanding α-globin gene regulation and implications for the treatment of β-thalassemia.Molecular basis of β thalassemia and potential therapeutic targets.In Vitro Hb Production in B-thalassemia Patients Is Not a Predictor of Clinical Responsiveness to HydroxyureaAn Aγ-globin G->A gene polymorphism associated with β039 thalassemia globin gene and high fetal hemoglobin production.Beta-thalassemia: from genotype to phenotype.Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.Changes in hematological parameters in α-thalassemia individuals co-inherited with erythroid Krüppel-like factor mutations.Utility of the multivariate approach in predicting β-thalassemia intermedia or β-thalassemia major types In Iranian patients.Annotated definition of BCL11A and HMIP-2 haplotypes through the analysis of sicilian β-thalassemia patients with high levels of fetal hemoglobin.Mutation in a Highly Conserved COOH-Terminal Residue of Krüppel-Like Factor 1 Associated with Elevated Hb F in a Compound Heterozygous β-Thalassemia Patient with a Nontransfusion-Dependent Thalassemia Phenotype.Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β0-Thalassemia Families with High Fetal Hemoglobin Levels.Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future ExpectationsTwo novel mutations (HBG1: c.-250C > T and HBG2: c.-250C > T) associated with hereditary persistence of fetal hemoglobin.
P2860
Q34322542-0064C890-9289-49B9-9514-1EA8E6437212Q35087288-DA4591E0-0929-4F47-8161-E40F930810DDQ35236041-E9596C69-AD9D-47F4-92E4-34B8B63C4056Q35836891-B742B90A-5C0F-47A3-B240-306102E0C15CQ36035471-F47A120F-4F31-4A1C-9660-37CACD588F29Q36062896-E85B4A1E-D894-4568-8452-A95B67270899Q36094672-D90385EF-B32C-4D57-B78D-68D67774E99EQ36554628-FBF8043C-91B1-4E21-A061-0129CDE59AE0Q36579150-30B7418F-04C1-4EA1-B08C-4AE850A5F115Q36892558-BCB9D382-F4CB-4425-A02C-E49516E567EBQ38167823-BEF2C7EB-E8FD-4738-AD40-60AB3E9FBAEBQ38170142-1EAD6C1F-16B2-4006-9605-3EA1FB2904E1Q38374011-73F87AFA-E34A-4FC1-A33B-5EE87C33D520Q38594354-0EF49670-8FC1-4E08-875D-05D6324F0B9DQ38676718-5CCE2246-3319-4CD6-A4BD-E0F1A154B094Q39399184-3FA9782A-E108-47C3-80FA-EE566CDDACE2Q41466551-5A418A41-B560-4895-85B4-01BD9A0F2883Q41554655-607DAF19-042F-4F71-A2CD-7ECF41D38801Q42958714-EE96BCA7-91CD-4299-8179-6F5AA8601516Q50061134-9FC9165A-10EF-450D-A516-3A5FA4D674E8Q50468655-7A4AE587-8004-4756-A2E8-92D33864788DQ50874039-A5BFCDBF-5D0F-4E08-84CA-A5E5FF4C28AEQ50897833-B5582F60-7415-44D0-8A70-6B1B4E5120DFQ51340480-DC1A91D9-7884-4115-9A65-2E583FC50A33Q53771829-9A3B2FCA-6E46-41DB-A6A2-3F93679E3947Q54585888-1FE3E25F-A425-4B50-B376-7CBDBBCDC84EQ54720454-9F3A3173-16DB-444E-8E09-61EBA9F5D005
P2860
Variants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Variants in genetic modifiers ...... intermedia type of the disease
@ast
Variants in genetic modifiers ...... intermedia type of the disease
@en
type
label
Variants in genetic modifiers ...... intermedia type of the disease
@ast
Variants in genetic modifiers ...... intermedia type of the disease
@en
prefLabel
Variants in genetic modifiers ...... intermedia type of the disease
@ast
Variants in genetic modifiers ...... intermedia type of the disease
@en
P2093
P2860
P1433
P1476
Variants in genetic modifiers ...... intermedia type of the disease
@en
P2093
Alain Francina
Anderson Loundou
Catherine Badens
Imane Agouti
Isabelle Thuret
Katia Gonnet
Marie-Claude Simeoni
Philippe Joly
Serge Pissard
Synda Fattoum
P2860
P304
P356
10.3324/HAEMATOL.2011.046748
P577
2011-07-26T00:00:00Z